These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4276557)

  • 1. Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
    Heine P; Kewitz H; Wiegboldt KA
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R30. PubMed ID: 4276557
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
    Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract]   [Full Text] [Related]  

  • 4. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
    Göschke H; Denes A; Girard J; Collard F; Berger W
    Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 9. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 10. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
    Willms B
    MMW Munch Med Wochenschr; 1975 Oct; 117(41):1643-8. PubMed ID: 810689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical experiences in oral antidiabetic therapy with sulphonylureas and biguanides.
    Schöffling K
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:47-56. PubMed ID: 5005131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood coagulation, fibrinolysis and kallikreinogenesis in diabetics with vascular complications treated with insulin or sulfonylurea derivatives].
    Kaniak J; Kotschy M; Kurzawska M; Paczyńska D
    Pol Tyg Lek; 1978 Jul; 33(27):1065-8. PubMed ID: 693380
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J
    Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
    [No Abstract]   [Full Text] [Related]  

  • 17. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical testing of a sulphonylurea derivative, glibornuride].
    Zöllner N; Dörfler H; Wolfram G
    Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radioimmunological determination of insulin in patients with manifest diabetes mellitus as a guide for the planning of therapy (author's transl)].
    Zilker T; Kränzlin T; Schweigart U; Ermler R; Bottermann P
    Med Klin; 1976 Apr; 71(18):761-7. PubMed ID: 818495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
    Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
    Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.